Klinique Medical Clinic PCL
SET:KLINIQ
Balance Sheet
Balance Sheet Decomposition
Klinique Medical Clinic PCL
Klinique Medical Clinic PCL
Balance Sheet
Klinique Medical Clinic PCL
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
83
|
102
|
9
|
76
|
464
|
108
|
248
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
108
|
248
|
|
| Cash Equivalents |
83
|
102
|
9
|
76
|
464
|
0
|
0
|
|
| Short-Term Investments |
20
|
0
|
0
|
0
|
1 000
|
1 060
|
531
|
|
| Total Receivables |
65
|
48
|
38
|
35
|
53
|
58
|
48
|
|
| Accounts Receivables |
25
|
41
|
38
|
35
|
53
|
58
|
48
|
|
| Other Receivables |
40
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
41
|
46
|
103
|
84
|
120
|
191
|
272
|
|
| Other Current Assets |
10
|
32
|
41
|
7
|
40
|
60
|
46
|
|
| Total Current Assets |
220
|
228
|
192
|
202
|
1 678
|
1 477
|
1 144
|
|
| PP&E Net |
202
|
281
|
511
|
534
|
818
|
1 216
|
1 795
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1 216
|
1 795
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
475
|
564
|
|
| Intangible Assets |
1
|
1
|
1
|
2
|
4
|
4
|
5
|
|
| Note Receivable |
0
|
133
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
52
|
56
|
69
|
75
|
91
|
149
|
175
|
|
| Total Assets |
474
N/A
|
700
+48%
|
772
+10%
|
814
+5%
|
2 590
+218%
|
2 846
+10%
|
3 118
+10%
|
|
| Liabilities | ||||||||
| Accounts Payable |
74
|
126
|
94
|
126
|
201
|
89
|
117
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
85
|
86
|
|
| Short-Term Debt |
0
|
0
|
13
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
50
|
58
|
71
|
90
|
128
|
|
| Other Current Liabilities |
395
|
267
|
335
|
315
|
433
|
501
|
534
|
|
| Total Current Liabilities |
470
|
395
|
493
|
499
|
705
|
766
|
865
|
|
| Long-Term Debt |
3
|
5
|
149
|
149
|
234
|
371
|
530
|
|
| Deferred Income Tax |
0
|
6
|
14
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
6
|
5
|
5
|
5
|
5
|
6
|
6
|
|
| Total Liabilities |
480
N/A
|
411
-14%
|
661
+61%
|
654
-1%
|
944
+44%
|
1 143
+21%
|
1 401
+23%
|
|
| Equity | ||||||||
| Common Stock |
80
|
80
|
80
|
80
|
110
|
110
|
110
|
|
| Retained Earnings |
87
|
208
|
30
|
79
|
132
|
189
|
203
|
|
| Additional Paid In Capital |
12
|
12
|
12
|
12
|
1 415
|
1 415
|
1 415
|
|
| Other Equity |
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Total Equity |
6
N/A
|
289
N/A
|
111
-61%
|
161
+44%
|
1 646
+925%
|
1 703
+3%
|
1 717
+1%
|
|
| Total Liabilities & Equity |
474
N/A
|
700
+48%
|
772
+10%
|
814
+5%
|
2 590
+218%
|
2 846
+10%
|
3 118
+10%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
220
|
220
|
220
|
220
|
220
|
220
|
220
|
|